Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (511-520 of 4,677) with videos related to

Pageof 468
Sort By:
Cancer Discovery|November 1, 2023
Correction: Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
Cancer Discovery|December 17, 2025
Clonal Hematopoiesis Enhances Immunotherapy Response in Solid Tumors
Cancer Discovery|December 17, 2025
Circulating Tumor Cell Infiltration of Major Vessels Influences Cancer Prognosis
Cancer Discovery|December 17, 2025
T-cell Aggregation in Antigen-presenting Pockets Promotes Tumor Killing
Cancer Discovery|December 2, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint BlockadePei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.
Cancer Discovery|June 13, 2025
Germline-somatic liaison dictates cancer subtype via de novo steroid biosynthesisPaola Gasperini, Alessandro Alaimo, Blerta Stringa, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Cancer Discovery|June 24, 2025
AAnet resolves a continuum of spatially-localized cell states to unveil intratumoral heterogeneityAarthi Venkat, Scott E Youlten, Beatriz P San Juan, et al.
Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.
Cancer Discovery|October 9, 2025
Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma ProgressionDaniel D Azorín, Dirk C Hoffmann, Nils R Hebach, et al.
Pageof 468

Showing results (511-520 of 4,677) with videos related to

Sort By:
Pageof 468
Cancer Discovery|November 1, 2023
Correction: Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
Cancer Discovery|December 17, 2025
Clonal Hematopoiesis Enhances Immunotherapy Response in Solid Tumors
Cancer Discovery|December 17, 2025
Circulating Tumor Cell Infiltration of Major Vessels Influences Cancer Prognosis
Cancer Discovery|December 17, 2025
T-cell Aggregation in Antigen-presenting Pockets Promotes Tumor Killing
Cancer Discovery|December 2, 2025
Editor's Note: Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint BlockadePei-Ling Chen, Whijae Roh, Alexandre Reuben, et al.
Cancer Discovery|June 13, 2025
Germline-somatic liaison dictates cancer subtype via de novo steroid biosynthesisPaola Gasperini, Alessandro Alaimo, Blerta Stringa, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Cancer Discovery|June 24, 2025
AAnet resolves a continuum of spatially-localized cell states to unveil intratumoral heterogeneityAarthi Venkat, Scott E Youlten, Beatriz P San Juan, et al.
Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.
Cancer Discovery|October 9, 2025
Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma ProgressionDaniel D Azorín, Dirk C Hoffmann, Nils R Hebach, et al.
Pageof 468